Literature DB >> 2715350

Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours.

S M Sjöblom1, P Sipponen, S L Karonen, H J Järvinen.   

Abstract

The number and density of argyrophil endocrine cells were morphometrically calculated in gastric fundal mucosal biopsy specimens taken from 64 patients with pernicious anaemia (five with gastric carcinoids, 15 with nodular argyrophil cell hyperplasia, 44 with diffuse argyrophil cell hyperplasia) and from 14 healthy controls. Similar calculations were also made on the ileal mucosa away from the tumour of 10 patients with ileal carcinoids and 10 controls. In the stomach, the argyrophil cell counts were twice as high in the patients with pernicious anaemia than in controls and the densities in the whole mucosa or in the epithelial structures were similarly three to five times higher. The cell counts in the patients showed positive correlation with the serum gastrin concentration. The patients with nodular argyrophil cell hyperplasia and gastric carcinoids formed a uniform group with the highest cell counts and serum gastrin concentrations; the difference between the groups was in the longer duration of pernicious anaemia in the patients with carcinoid tumours. On the other hand, no endocrine cell hyperplasia was seen in those with ileal carcinoids. It is concluded that fundal mucosal endocrine cells show an increase in patients with pernicious anaemia that is related to the gastrin concentration. This phenomenon may favour the development of hyperplastic endocrine cell nodules and, eventually, carcinoid tumours.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715350      PMCID: PMC1141907          DOI: 10.1136/jcp.42.4.371

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  [The argentaffin system of the gastrointestinal tract in the carcinoid syndrome].

Authors:  C Hedinger; T Hardmeier; H U Funk
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1966-02-22

Review 2.  Silver stains in the study of endocrine cells of the gut and pancreas.

Authors:  L Grimelius; E Wilander
Journal:  Invest Cell Pathol       Date:  1980 Jan-Mar

3.  Gastric neuroendocrine cell hyperplasia after treatment with the long-acting, potent H2-receptor antagonist SK&F 93479.

Authors:  J H Harleman; G R Betton; C Dormer; M McCrossan
Journal:  Scand J Gastroenterol       Date:  1987-06       Impact factor: 2.423

Review 4.  Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach.

Authors:  R Håkanson; G Böttcher; F Sundler; S Vallgren
Journal:  Digestion       Date:  1986       Impact factor: 3.216

5.  Gastric carcinoid associated with the syndrome of hypergastrinemic atrophic gastritis. A prospective analysis of 11 cases.

Authors:  K Borch; H Renvall; E Kullman; E Wilander
Journal:  Am J Surg Pathol       Date:  1987-06       Impact factor: 6.394

6.  Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia.

Authors:  R F Harvey; M J Bradshaw; C M Davidson; S P Wilkinson; P S Davies
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

7.  Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa.

Authors:  K Borch; H Renvall; G Liedberg; B N Andersen
Journal:  Scand J Gastroenterol       Date:  1986-04       Impact factor: 2.423

8.  Development of gastric argyrophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long-term antisecretory treatment.

Authors:  M Mignon; T Lehy; A Bonnefond; P Ruszniewski; D Labeille; S Bonfils
Journal:  Cancer       Date:  1987-06-01       Impact factor: 6.860

9.  Immunoreactive gastrin components in human serum.

Authors:  J F Rehfeld; F Stadil; J Vikelsoe
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

10.  A clinical study of 30 gastric carcinoids.

Authors:  H Johansson; E Wilander
Journal:  Ups J Med Sci       Date:  1982       Impact factor: 2.384

View more
  17 in total

1.  Amphicrine tumor.

Authors:  L Mándoky
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Changes of the gastric endocrine cells in the C57BL/6 mouse after implantation of murine lung carcinoma: an immunohistochemical quantitative study.

Authors:  Sae-Kwang Ku; Hyeung-Sik Lee; Joon-Seok Byun; Bu-Il Seo; Jae-Hyun Lee
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 3.  [Therapy of carcinoids of the stomach].

Authors:  H D Becker; A Gabriel
Journal:  Langenbecks Arch Chir       Date:  1996

4.  Changes of the intestinal endocrine cells in the C57BL/6 mouse after implantation of murine lung carcinoma (3LL): an immunohistochemical quantitative study.

Authors:  Sae-Kwang Ku; Seung-Kyoo Seong; Dae-Young Kim; Hyeung-Sik Lee; Jong-Dae Kim; Hae-Yun Choi; Bu-Il Seo; Jae-Hyun Lee
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

5.  Gastroscopic follow up of pernicious anaemia patients.

Authors:  S M Sjöblom; P Sipponen; H Järvinen
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

Review 6.  Pathophysiological effects of long-term acid suppression in man.

Authors:  R F McCloy; R Arnold; K D Bardhan; D Cattan; E Klinkenberg-Knol; P N Maton; R H Riddell; P Sipponen; A Walan
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship.

Authors:  E Brenna; H L Waldum
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

Review 8.  Histamine metabolism of gastric carcinoids in Mastomys natalensis.

Authors:  L Kölby; B Wängberg; H Ahlman; I M Modlin; O Nilsson
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 9.  Diagnosis and treatment of ECL cell tumors.

Authors:  G Cadiot; D Cattan; M Mignon
Journal:  Yale J Biol Med       Date:  1998 May-Aug

Review 10.  Gastrin and the Moderate Hypergastrinemias.

Authors:  Jens F Rehfeld
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.